Comment diagnostique-t-on une cardiopathie congénitale ?

Le diagnostic se fait par échocardiographie, radiographie thoracique et électrocardiogramme.

Quels tests sont utilisés pour évaluer la gravité ?

Des tests comme l'IRM cardiaque et les tests de stress peuvent évaluer la gravité.

Les symptômes peuvent-ils aider au diagnostic ?

Oui, des symptômes comme la cyanose ou l'essoufflement peuvent indiquer une cardiopathie.

Quand doit-on consulter un cardiologue pédiatrique ?

Il est conseillé de consulter si des anomalies cardiaques sont suspectées à la naissance.

Les antécédents familiaux influencent-ils le diagnostic ?

Oui, des antécédents familiaux de cardiopathies peuvent augmenter le risque de diagnostic.

Quels sont les symptômes courants des cardiopathies congénitales ?

Les symptômes incluent la cyanose, la fatigue, l'essoufflement et des battements cardiaques rapides.

La cyanose est-elle un symptôme fréquent ?

Oui, la cyanose, qui se manifeste par une coloration bleutée de la peau, est fréquente.

Les nourrissons présentent-ils des symptômes visibles ?

Oui, les nourrissons peuvent montrer des signes comme une mauvaise alimentation et une irritabilité.

Les symptômes varient-ils selon le type de malformation ?

Oui, les symptômes peuvent varier considérablement selon le type de cardiopathie congénitale.

Les enfants plus âgés peuvent-ils avoir des symptômes différents ?

Oui, les enfants plus âgés peuvent présenter des symptômes comme des douleurs thoraciques ou des palpitations.

Peut-on prévenir les cardiopathies congénitales ?

Certaines cardiopathies peuvent être prévenues par des soins prénatals appropriés et des vaccinations.

Quel rôle joue la génétique dans la prévention ?

La génétique peut influencer le risque, donc un conseil génétique peut être utile pour les familles.

Les femmes enceintes doivent-elles éviter certains médicaments ?

Oui, certaines substances comme les médicaments tératogènes doivent être évitées pendant la grossesse.

L'alimentation de la mère influence-t-elle le risque ?

Oui, une alimentation équilibrée et riche en acide folique peut réduire le risque de malformations.

Les infections pendant la grossesse sont-elles un risque ?

Oui, certaines infections comme la rubéole peuvent augmenter le risque de cardiopathies congénitales.

Quels traitements sont disponibles pour les cardiopathies congénitales ?

Les traitements incluent la médication, la chirurgie et les interventions par cathéter.

La chirurgie est-elle toujours nécessaire ?

Non, certaines cardiopathies peuvent être gérées par des médicaments sans chirurgie.

Quels médicaments sont souvent prescrits ?

Des médicaments comme les diurétiques et les inhibiteurs de l'enzyme de conversion sont courants.

Les interventions par cathéter sont-elles efficaces ?

Oui, elles sont souvent efficaces pour corriger certaines malformations sans chirurgie ouverte.

Quel suivi est nécessaire après le traitement ?

Un suivi régulier avec un cardiologue est essentiel pour surveiller l'évolution de la condition.

Quelles complications peuvent survenir avec ces cardiopathies ?

Les complications incluent l'insuffisance cardiaque, les arythmies et les infections cardiaques.

Les cardiopathies congénitales augmentent-elles le risque d'AVC ?

Oui, certaines malformations peuvent augmenter le risque d'accidents vasculaires cérébraux.

Les patients doivent-ils surveiller leur santé cardiaque ?

Oui, un suivi régulier est crucial pour détecter et gérer les complications potentielles.

Les complications peuvent-elles survenir à l'âge adulte ?

Oui, certaines complications peuvent se manifester à l'âge adulte, nécessitant un suivi continu.

Les infections cardiaques sont-elles fréquentes ?

Oui, les patients avec cardiopathies congénitales sont à risque accru d'infections cardiaques.

Quels sont les principaux facteurs de risque ?

Les facteurs incluent des antécédents familiaux, des infections maternelles et des médicaments.

L'alcool pendant la grossesse est-il un facteur de risque ?

Oui, la consommation d'alcool pendant la grossesse peut augmenter le risque de malformations cardiaques.

Le diabète maternel influence-t-il le risque ?

Oui, le diabète non contrôlé chez la mère peut augmenter le risque de cardiopathies congénitales.

Les médicaments pris par la mère peuvent-ils affecter le fœtus ?

Oui, certains médicaments peuvent être tératogènes et affecter le développement cardiaque du fœtus.

Le tabagisme maternel est-il un risque ?

Oui, le tabagisme pendant la grossesse est associé à un risque accru de malformations cardiaques.

Cardiopathies congénitales - Informations médicales vérifiées

On the involvement of the second heart field in congenital heart defects.

15 Mar 2024

DOI: 10.5802/crbiol.151 PMID: 38488639

Congenital heart defects (CHD) affect 1 in 100 live births and result from defects in cardiac development. Growth of the early heart tube occurs by the progressive addition of second heart field (SHF)...

Humans Heart Heart Defects, Congenital Myocardium Stem Cells +1 autres

Elevated risk for developmental disabilities in children with congenital heart defects.

01 11 2023

DOI: 10.1002/bdr2.2246 PMID: 37681320

This study examined risk for developmental disabilities in preschool-aged children with a congenital heart defect (CHD) at the population level.... Statewide birth, birth defects, and preschool developmental disability records were integrated. The final sample included 1,966,585 children (51.0% male). Children were grouped by type(s) of CHD: crit... Children with a CHD (any type) were at increased risk for developmental disability (any type) (RR 2.08, 95% CI 2.03-2.14, P < .001). Children in the critical CHD, noncritical CHD, and atrial septal de... Increased risk for developmental disabilities was identified for children with less severe CHDs as well as for children with more severe (critical) CHDs. All children with CHDs should be closely monit...

Humans Male Child Child, Preschool Female +5 autres

Epigenomic signature of major congenital heart defects in newborns with Down syndrome.

06 Oct 2023

DOI: 10.1186/s40246-023-00540-1 PMID: 37803336

Congenital heart defects (CHDs) affect approximately half of individuals with Down syndrome (DS), but the molecular reasons for incomplete penetrance are unknown. Previous studies have largely focused... We used the Illumina EPIC array and whole-genome bisulfite sequencing (WGBS) to quantitate DNA methylation for 86 NDBS samples from the California Biobank Program: (1) 45 DS-CHD (27 female, 18 male) a... We found global CpG hypomethylation in DS-CHD males compared to DS non-CHD males, which was attributable to elevated levels of nucleated red blood cells and not seen in females. At a regional level, w... A sex-specific signature of DNA methylation was detected in NDBS of DS-CHD compared to DS non-CHD individuals. This supports the hypothesis that epigenetics can reflect the variability of phenotypes i...

Humans Male Infant, Newborn Female Down Syndrome +6 autres

Maternal Oxidative Balance Score during Pregnancy and Congenital Heart Defects.

11 Jun 2024

DOI: 10.3390/nu16121825 PMID: 38931180

The relationship between maternal oxidative balance score (OBS) in pregnancy, representing overall oxidative balance status by integrating dietary and lifestyle factors, and congenital heart defects (...

Humans Female Pregnancy Heart Defects, Congenital Adult +10 autres

Progesterone for Neurodevelopment in Fetuses With Congenital Heart Defects: A Randomized Clinical Trial.

01 May 2024

DOI: 10.1001/jamanetworkopen.2024.12291 PMID: 38805228

Neurodevelopmental outcomes for children with congenital heart defects (CHD) have improved minimally over the past 20 years.... To assess the feasibility and tolerability of maternal progesterone therapy as well as the magnitude of the effect on neurodevelopment for fetuses with CHD.... This double-blinded individually randomized parallel-group clinical trial of vaginal natural progesterone therapy vs placebo in participants carrying fetuses with CHD was conducted between July 2014 a... Participants were 1:1 block-randomized to vaginal progesterone or placebo by diagnosis: hypoplastic left heart syndrome (HLHS), transposition of the great arteries (TGA), and other CHD diagnoses. Trea... The primary outcome was the motor score of the Bayley Scales of Infant and Toddler Development-III; secondary outcomes included language and cognitive scales. Exploratory prespecified subgroups includ... The 102 enrolled fetuses primarily had HLHS (n = 52 [50.9%]) and TGA (n = 38 [37.3%]), were more frequently male (n = 67 [65.7%]), and without genetic anomalies (n = 61 [59.8%]). The mean motor score ... In this randomized clinical trial of maternal progesterone therapy, the overall effect was not statistically different from 0. Subgroup analyses suggest heterogeneity of the response to progesterone a... ClinicalTrials.gov Identifier: NCT02133573....

Humans Progesterone Female Heart Defects, Congenital Male +8 autres

Prognostic value of cardiopulmonary exercise test in children with congenital heart defects.

19 Aug 2024

DOI: 10.1136/openhrt-2024-002820 PMID: 39160087

Cardiopulmonary exercise testing (CPET) has an important prognostic value in adults with different congenital heart defects (CHDs) and is a useful tool for risk stratification and clinical decision-ma... 411 CPET performed by paediatric patients with different CHDs were evaluated in this retrospective study. Medical records were reviewed to determine the presence of cardiac events. Participants were c... 411 patients with a median age at test of 12 years, 51 patients with simple CHD, 170 patients with moderate complexity CHD and 190 with high complexity CHD underwent CPET. Overall, CPET parameters wer... Reduced exercise capacity at young age is related to a higher probability of future cardiovascular events in paediatric patients with CHD. Submaximal exercise variables can be used instead when maxima...

Humans Heart Defects, Congenital Retrospective Studies Exercise Test Male +10 autres

A machine learning model for predicting congenital heart defects from administrative data.

01 11 2023

DOI: 10.1002/bdr2.2245 PMID: 37681293

International Classification of Diseases (ICD) codes recorded in administrative data are often used to identify congenital heart defects (CHD). However, these codes may inaccurately identify true posi... To identify features relevant to accurate CHD identification, traditional ML models were applied to a validated dataset of 779 patients; encounter level data, including ICD-9-CM and CPT codes, from 20... Baseline PPV was 76.5% from expert clinician validation of ICD-9-CM CHD-related codes. Feature selection for ML decreased 7138 features to 10 that best predicted TP CHD cases. During training and test... Applying ML algorithms improved the accuracy of identifying TP CHD cases in comparison to ICD codes alone. Use of this technique to identify CHD cases would improve generalizability of results obtaine...

Humans Bayes Theorem Heart Defects, Congenital Predictive Value of Tests Algorithms +1 autres

Maternal cardiovascular health in early pregnancy and the risk of congenital heart defects in offspring.

26 Apr 2024

DOI: 10.1186/s12884-024-06529-5 PMID: 38671408

Congenital heart disease (CHD) is the predominant birth defect. This study aimed to explore the association between maternal cardiovascular health (CVH) and the CHD risk in offspring.... We used the prospective data from the Fujian Birth Cohort Study, collected from March 2019 to December 2022 on pregnant women within 14 weeks of gestation. Overall maternal CVH was assessed by seven C... A total of 19810 participants aged 29.7 (SD: 3.9) years were included, with 7846 (39.6%) classified as having high CVH, 10949 (55.3%) as having moderate CVH, and 1015 (5.1%) as having low CVH. The ave... Pregnant women of high or moderate CVH categories in early pregnancy had reduced risks of CHD in offspring, compared to those of low CVH. It is important to monitor and improve CVH during pre-pregnanc...

Humans Female Pregnancy Heart Defects, Congenital Adult +7 autres

Maternal modifiable factors and risk of congenital heart defects: systematic review and causality assessment.

24 Aug 2024

DOI: 10.1136/bmjopen-2023-082961 PMID: 39181550

Primary prevention strategies are critical to reduce the global burden of congenital heart defects (CHDs); this requires robust knowledge of causal agents. We aimed to review associations between CHDs... Systematic review of reviews with application of a Bradford Hill criteria score-based causal assessment system.... We searched PubMed, Embase and Episteminokos (January 1990-April 2023).... Systematic reviews of original epidemiological studies reporting association (relative risk) between one or more of the above maternal factors and CHDs overall (any type) in subsequent offspring.... Two independent reviewers selected eligible reviews, assessed the risk of bias and assigned the strength of evidence for causality.... There was strong evidence of a causal relationship between CHDs and maternal obesity (prepregnancy and early pregnancy) and pre-existing diabetes (six of seven Bradford Hill criteria met). For pre-exi... CHDs can be reduced with stronger action to reduce maternal obesity and pre-existing diabetes prevalence. Investigating environmental exposures that have received limited attention, such as air pollut...

Humans Heart Defects, Congenital Female Pregnancy Risk Factors +7 autres

7p22.3 microdeletion: a case study of a patient with congenital heart defect, neurodevelopmental delay and epilepsy.

16 Aug 2024

DOI: 10.1186/s13023-024-03321-8 PMID: 39152504

Chromosome 7 has regions enriched with low copy repeats (LCRs), which increase the likelihood of chromosomal microdeletion disorders. Documented microdeletion disorders on chromosome 7 include both we... The article describes a clinical case of 7p22.3 microdeletion in a patient with congenital heart defect and neurological abnormalities - epilepsy, combined with moderate mental and motor developmental... Through detailed genetic analyses, we are improving the clinical description of the rare 7p22.3 microdeletion and thus creating a basis for future genetic counseling and research into targeted therapi...

Humans Heart Defects, Congenital Chromosomes, Human, Pair 7 Epilepsy Chromosome Deletion +4 autres

Cardiopathies congénitales : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Diagnostic 5

Symptômes 5

Prévention 5

Traitements 5

Complications 5

Facteurs de risque 5

Contenu validé par Dr Olivier Menir

Sous-catégories

Coarctation aortique

Tunnel aorto-ventriculaire

Dysplasie ventriculaire droite arythmogène

Maladie de la valve aortique bicuspide

Coeur triatrial

Anomalies congénitales des vaisseaux coronaires

Coeur croisé

Persistance du canal artériel

Maladie d'Ebstein

Ectopie cardiaque

Complexe d'Eisenmenger

Malformations des cloisons cardiaques

Syndrome d'hétérotaxie

Hypoplasie du coeur gauche

Valve aortique quadricuspide

Tétralogie de Fallot

Transposition des gros vaisseaux

Atrésie tricuspide

Trilogie de Fallot

Cœur univentriculaire

Syndrome de Wolff-Parkinson-White

Anomalie de l'artère coronaire gauche

Pont myocardique

Communication aortopulmonaire

Canal atrioventriculaire

Communications interauriculaires

Communications interventriculaires

Syndrome de Jervell et Lange Nielsen

Transposition congénitalement corrigée des gros vaisseaux

Ventricule droit à double issue

Tronc artériel commun

Foramen ovale perméable

Syndrome de Lutembacher

Auteurs principaux

Sources (10000 au total)